ASSET PURCHASE AGREEMENT by and between IBIO, INC. and OTSUKA PHARMACEUTICAL CO., LTD. Dated as of February 25, 2024Asset Purchase Agreement • February 26th, 2024 • iBio, Inc. • Pharmaceutical preparations • New York
This ASSET PURCHASE AGREEMENT (this “Agreement”) is entered into as of February 25, 2024, by and between iBio, Inc., a Delaware corporation (“Seller”), and Otsuka Pharmaceutical Co., Ltd., a company organized under the Laws of Japan (“Buyer”). Hereinafter, “Parties” shall mean Seller and Buyer together, and “Party” shall mean either Seller or Buyer, as the context requires.
